2Wieser F, Fabjani G, Tempfer C, et al. Tumor necrosis factor-α promotor polymorphisms and endometriosis. J Soc Gynecol Investig, 2002,9:313-317.
3Skeie GO, Pandey JP, Aarli JA, et al. TNFA and TNFB polymorphisms in myasthenia gravis. Arch Neurol, 1999 ,56: 457 -461.
4Wilson A G, de Vries N, Pociot F, et al. An allelic polymorphism within the human tumor necrosis factor promotor region is strongly associated with HLA-A1, 138, DR3 alleles. J Exp Med, 1993,177:557-560.
5Webb G C, Chaplin D D. Genetic variability at the human tumor necrosis factor Loci, J Immunol,1990, 145 : 1278-1285.
6Lee MK, Park AJ, Kim DH. Tumor necrosis factor-α and interleukin-6 promoter gene polymorphisms are not associated with an increased risk of endometriosis. Fertil steril, 2002, 77: 1304-1305.
7Hsieh YY, Chang CC, Tsai FJ, et al. Polymorphisms for interleukin-4 (IL-4) -590 promoter, IL-4 intron3, and tumor necrosis factor alpha -308 promoter: non-association with endometriosis. J Clin Lab Anal, 2002,16:121-126.
8Teramoto M, Kitawaki J, Koshiba H, et al. Genetic contribution of tumor necrosis factor TNF-alpha gene promoter (-1031, -863 and -857 ) and TNF receptor 2 gene polymorphisms in endometriosis susceptibility. Am J Beprod Immunol, 2004,51 : 352-357.
9Asghar T, Yoshida S, Kennedy S, et al. The tumor necrosis factor-{alpha} promoter -1031C polymorphism is associated with decreased risk of endometriosis in a Japanese population. Hum Reprod,2004:19.
10Selam B, Arici A. Imp lantation defect in endometriosis: endometrium or peritoneal fluid. J Rep rod Fertil Suppl, 2000, 55: 121-128.
